THE USE OF ANTIPSYCHOTICS IN THE REAL-WORLD CLINICAL PRACTICE IN RUSSIA (BASED ON THE RESULTS OF THE EPIDEMICUS PROGRAM); ПРИМЕНЕНИЕ АНТИПСИХОТИКОВ В РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКЕ В РОССИИ (ПО РЕЗУЛЬТАТАМ ПРОГРАММЫ EPIDEMICUS) ArticleMedvedevНаучно-практическая ревматология. Том 17. 2025. С. 24-33
GENDER IDENTITY DISORDERS IN SCHIZOPHRENIA ArticleMedvedev V.E., Gushansky S.I.Неврологический вестник. Том 57. 2025. С. 12-19
MENTAL DISORDERS IN PATIENTS WITH CARDIOVASCULAR DISEASES. CONSENSUS STATEMENT BY THE TASK FORCE OF THE RUSSIAN SOCIETY OF CARDIOLOGY AND THE RUSSIAN SOCIETY OF PSYCHIATRISTS ArticleBelyalov Farid I., Veltishchev D.Yu, Volel B.A., Garganeeva Natalya P., Kopylov F.Yu, Lareva Natalia V., Medvedev V.E., Mosolov Sergey Nikolaevich, Petrova Marina M., Petrunko Olga V., Poponina Tatiana M., Repin Aleksey N., Sobennikov Vasiliy S., Sumin Aleksei N.Kardiologiya. Том 65. 2025. С. 54-73
EFFICACY AND SAFETY OF FABOMOTIZOLE (AFOBAZOL® RETARD) IN PATIENTS WITH ADJUSTMENT DISORDERS FOLLOWING CORONAVIRUS INFECTION (COVID-19): RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ArticleDorofeeva O.A., Nekrasov V.A., Medvedev V.E., Poromov Artem A., Zaǐnullina Liana Fanzilevna, Kalinina Oksana Vladimirovna, Seredenin Sergey BorisovichСовременная терапия психических расстройств. Том 2025. 2025. С. 11-23
EFFECTIVENESS AND TOLERABILITY OF AGOMELATINE (VALDOXAN) IN THE TREATMENT OF DEPRESSION AFTER COVID-19 (TELESFOR STUDY) ArticleMedvedev V.E., Bogolepova A.N.Журнал неврологии и психиатрии им. C.C. Корсакова. Том 125. 2025. С. 90-98
AGOMELATINE FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER ArticleMedvedevСовременная терапия психических расстройств. Том 2024. 2024. С. 55-65